Fibroblast Growth Factor 23 and the Last Mile

被引：3

作者：

Gutierrez, Orlando M. ^{[1
,2
]}

机构：

[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

[2] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2020年 / 15卷 / 09期

关键词：

hyperphosphatemia; mineral metabolism; cardiovascular disease; fibroblast growth factor 23; Fibroblast Growth Factors; Diagnostic Tests; Routine; DISEASE;

D O I：

10.2215/CJN.13631119

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

100201 [内科学]; 100221 [泌尿外科学];

摘要：

[No abstract available]

引用

页码：1355 / 1357

页数：3

共 10 条

[1]

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production [J].

David, Valentin ;

Martin, Aline ;

Isakova, Tamara ;

Spaulding, Christina ;

Qi, Lixin ;

Ramirez, Veronica ;

Zumbrennen-Bullough, Kimberly B. ;

Sun, Chia Chi ;

Lin, Herbert Y. ;

Babitt, Jodie L. ;

Wolf, Myles .

KIDNEY INTERNATIONAL, 2016, 89 (01) :135-146

[2]

Cardiac actions of fibroblast growth factor 23 [J].

Faul, Christian .

BONE, 2017, 100 :69-79

[3]

FGF23 induces left ventricular hypertrophy [J].

Faul, Christian ;

Amaral, Ansel P. ;

Oskouei, Behzad ;

Hu, Ming-Chang ;

Sloan, Alexis ;

Isakova, Tamara ;

Gutierrez, Orlando M. ;

Aguillon-Prada, Robier ;

Lincoln, Joy ;

Hare, Joshua M. ;

Mundel, Peter ;

Morales, Azorides ;

Scialla, Julia ;

Fischer, Michael ;

Soliman, Elsayed Z. ;

Chen, Jing ;

Go, Alan S. ;

Rosas, Sylvia E. ;

Nessel, Lisa ;

Townsend, Raymond R. ;

Feldman, Harold I. ;

Sutton, Martin St. John ;

Ojo, Akinlolu ;

Gadegbeku, Crystal ;

Di Marco, Giovana Seno ;

Reuter, Stefan ;

Kentrup, Dominik ;

Tiemann, Klaus ;

Brand, Marcus ;

Hill, Joseph A. ;

Moe, Orson W. ;

Kuro-o, Makoto ;

Kusek, John W. ;

Keane, Martin G. ;

Wolf, Myles .

JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (11) :4393-4408

[4]

Fibroblast Growth Factor 23 and Disordered Vitamin D Metabolism in Chronic Kidney Disease: Updating the "Trade-off" Hypothesis [J].

Gutierrez, Orlando M. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (09) :1710-1716

[5]

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD [J].

Isakova, Tamara ;

Ix, Joachim H. ;

Sprague, Stuart M. ;

Raphael, Kalani L. ;

Fried, Linda ;

Gassman, Jennifer J. ;

Raj, Dominic ;

Cheung, Alfred K. ;

Kusek, John W. ;

Flessner, Michael F. ;

Wolf, Myles ;

Block, Geoffrey A. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (10) :2328-2339

[6]

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis [J].

Marthi, Amarnath ;

Donovan, Killian ;

Haynes, Richard ;

Wheeler, David C. ;

Baigent, Colin ;

Rooney, Christopher M. ;

Landray, Martin J. ;

Moe, Sharon M. ;

Yang, Jun ;

Holland, Lisa ;

di Giuseppe, Romina ;

Bouma-de Krijger, Annet ;

Mihaylova, Borislava ;

Herrington, William G. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (07) :2015-2027

[7]

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial [J].

Moe, Sharon M. ;

Chertow, Glenn M. ;

Parfrey, Patrick S. ;

Kubo, Yumi ;

Block, Geoffrey A. ;

Correa-Rotter, Ricardo ;

Drueeke, Tilman B. ;

Herzog, Charles A. ;

London, Gerard M. ;

Mahaffey, Kenneth W. ;

Wheeler, David C. ;

Stolina, Maria ;

Dehmel, Bastian ;

Goodman, William G. ;

Floege, Juergen .

CIRCULATION, 2015, 132 (01) :27-39

[8]

FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality [J].

Shalhoub, Victoria ;

Shatzen, Edward M. ;

Ward, Sabrina C. ;

Davis, James ;

Stevens, Jennitte ;

Bi, Vivian ;

Renshaw, Lisa ;

Hawkins, Nessa ;

Wang, Wei ;

Chen, Ching ;

Tsai, Mei-Mei ;

Cattley, Russell C. ;

Wronski, Thomas J. ;

Xia, Xuechen ;

Li, Xiaodong ;

Henley, Charles ;

Eschenberg, Michael ;

Richards, William G. .

JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (07) :2543-2553

[9]

Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease [J].

Singh, Saurav ;

Grabner, Alexander ;

Yanucil, Christopher ;

Schramm, Karla ;

Czaya, Brian ;

Krick, Stefanie ;

Czaja, Mark J. ;

Bartz, Rene ;

Abraham, Reimar ;

Di Marco, Giovana S. ;

Brand, Marcus ;

Wolf, Myles ;

Faul, Christian .

KIDNEY INTERNATIONAL, 2016, 90 (05) :985-996

[10]

Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease [J].

Udell, Jacob A. ;

Morrow, David A. ;

Jarolim, Petr ;

Sloan, Sarah ;

Hoffman, Elaine B. ;

O'Donnell, Thomas F. ;

Vora, Amit N. ;

Omland, Torbjorn ;

Solomon, Scott D. ;

Pfeffer, Marc A. ;

Braunwald, Eugene ;

Sabatine, Marc S. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (22) :2421-2428

← 1 →